Carterra Inc. announces its 2025 Symposia Series on accelerating drug discovery through AI/ML and other advanced technologies. Experts from top research institutions, including Pfizer, GSK, Bio-Techne, as well as co-hosts ImmunoPrecise Antibodies (IPA), ACROBiosystems, and Curia, will deliver presentations. The series, titled "Unlocking High-Throughput Biology in Drug Discovery," consists of four one-day events held in key cities across the U.S. and Europe: May 6, 2025: Boston, Massachusetts, USA June 4, 2025: Munich, Germany June 6, 2025: Cambridge, United Kingdom June 24, 2025: San Francisco, California, USA These symposia are specifically designed for drug discovery scientists and will cover a range of topics, including antibody and large molecule discovery, small molecule discovery, and cutting-edge applications like machine learning and AI in protein engineering. Other areas of focus include emerging oncology targets, the engineering of bispecific and multifunctional antibodies, library generation, biophysical characterization, and high-definition epitope binning to develop novel biotherapeutics. The lineup of speakers includes prominent scientists from The Institute for Protein Innovation (IPI), Pfizer, GSK, ACROBiosystems, Bio-Techne, Curia, ImmunoPrecise Antibodies (IPA), Ordaos, The Pirbright Institute, the University of Oxford, and the University of Pennsylvania. Carterra will also unveil new data from its recently launched Carterra Ultra™ platform, which was announced in September 2024. This instrument offers comprehensive small and large molecule applications, maintains the gold-standard SPR detection, and retains the high-throughput capabilities and minimal sample requirements of Carterra’s previous LSA and LSAXT systems. Chris Silva, Carterra's Vice President of Marketing and Product, commented, "Our past symposia attendees have consistently praised the diverse array of presentations and the collaborative, open atmosphere. We anticipate another year of record attendance and premium content." The events are structured to provide ample opportunities for scientific discussion and networking, with lunch included and free admission. Early registration is encouraged to secure a spot: https://carterra-bio.com/free-symposia-2025-unlocking-high-throughput-biology/ About Carterra, Inc. Carterra® is a leading provider of innovative technologies that speed up the discovery of novel therapeutic candidates. Its high-throughput LSA, LSAXT, and Ultra platforms combine patented microfluidics technology with real-time Surface Plasmon Resonance (SPR) and advanced analysis and visualization software. These systems can achieve up to 100 times the throughput in just 10% of the time while using only 1% of the sample volume compared to traditional label-free platforms. The LSAXT and Ultra instruments build on the capabilities of Carterra’s flagship LSA system, offering enhanced sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis.